Pub. Date : 2013
PMID : 23918070
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The inhibitor of the EML4/ALK fusion protein, crizotinib, has recently become a standard second-line treatment for patients with the gene rearrangement and has promise for patients with the ROS1 rearrangement. | Crizotinib | ROS proto-oncogene 1, receptor tyrosine kinase | Homo sapiens |